A detailed history of Diversified, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Diversified, LLC holds 7,046 shares of ABBV stock, worth $1.43 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,046
Previous 6,264 12.48%
Holding current value
$1.43 Million
Previous $1.14 Million 5.96%
% of portfolio
0.15%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$154.79 - $180.76 $121,045 - $141,354
782 Added 12.48%
7,046 $1.21 Million
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $24,292 - $27,679
152 Added 2.49%
6,264 $1.14 Million
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $68,387 - $77,020
-497 Reduced 7.52%
6,112 $947,000
Q3 2023

Nov 02, 2023

SELL
$133.59 - $154.65 $29,924 - $34,641
-224 Reduced 3.28%
6,609 $985,000
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $17,491 - $21,766
-132 Reduced 1.9%
6,833 $920,000
Q1 2023

Apr 24, 2023

SELL
$144.61 - $166.54 $56,831 - $65,450
-393 Reduced 5.34%
6,965 $1.11 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $169,014 - $202,693
1,222 Added 19.92%
7,358 $1.19 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $434,571 - $498,425
3,238 Added 111.73%
6,136 $824,000
Q2 2022

Jul 19, 2022

SELL
$137.62 - $174.96 $13,899 - $17,670
-101 Reduced 3.37%
2,898 $444,000
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $21,380 - $26,527
-162 Reduced 5.12%
2,999 $486,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $214 - $271
2 Added 0.06%
3,161 $428,000
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $212 - $241
2 Added 0.06%
3,159 $341,000
Q2 2021

Jul 16, 2021

BUY
$105.21 - $117.21 $89,323 - $99,511
849 Added 36.79%
3,157 $356,000
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $2,352 - $2,590
23 Added 1.01%
2,308 $250,000
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $183,919 - $248,310
2,285 New
2,285 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Diversified, LLC Portfolio

Follow Diversified, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified, LLC with notifications on news.